GlassScriptPhysician profile
Marianne V Cusick
NPI 1033323878
$21,961.02
in general payments reported to CMS, 2019-2025
37 companies · $5,242 in 2025
The $5,242 reported for 2025 was more than what 89% of Colon & Rectal Surgery providers received nationally (typical 2025 total: $317).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,471 · 2020: $169 · 2021: $579 · 2022: $1,746 · 2023: $2,994 · 2024: $8,761 · 2025: $5,242.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $6,615 · Food and Beverage: $4,430 · Education: $4,150 · Travel and Lodging: $1,757 · Gift: $44.83.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $6,615.00 |
| Food and Beverage | $4,429.80 |
| Education | $4,150.00 |
| Travel and Lodging | $1,756.90 |
| Gift | $44.83 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $7,823.78 | 2020-2025 | Da Vinci Surgical System |
| Ethicon US, LLC | $7,044.35 | 2019-2025 | Echelon; Endopath, Harmonic, Enseal |
| Covidien LP | $1,200.00 | 2019 | |
| Medical Device Business Services, INC. | $1,174.75 | 2024 | |
| Thd America, INC. | $706.29 | 2022-2025 | |
| Pacira Pharmaceuticals Incorporated | $436.31 | 2019-2025 | Exparel, Iovera |
| Baxter Healthcare | $405.52 | 2019-2025 | Perclot, Tisseel |
| Tela Bio, INC. | $298.99 | 2019-2023 | Ovitex Reinforced Bioscaffold With Permanent Polymer (Ovitex) |
| Stryker Corporation | $247.78 | 2019 | |
| Activ Surgical, INC. | $204.90 | 2022-2024 | Activsight |
| Becton, Dickinson and Company | $202.24 | 2024 | Hemosphere |
| Integra Lifesciences Corporation | $181.74 | 2021-2022 | |
| Aroa Biosurgery Incorporated | $167.05 | 2025 | |
| Shire North American Group INC | $163.16 | 2019 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $153.68 | 2019-2024 | Xifaxan |
Show all 37 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Marianne Cusick listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.